Light-Based treatment trial offers hope for early skin cancer control
NCT ID NCT05680558
Summary
This study is testing whether a light-based blood treatment called photopheresis can help control early-stage cutaneous T-cell lymphoma (CTCL), a type of skin cancer. Researchers want to see if using this treatment earlier in the disease course, rather than just for late stages, can improve skin symptoms and quality of life. The trial will enroll 74 adults with early CTCL who haven't responded well to standard treatments like creams, light therapy, or medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Herbert Irving Pavilion
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.